SOURCE: Valera Pharmacuticals

November 01, 2006 07:30 ET

Valera Pharmaceuticals Sets Date for Reporting Third-Quarter 2006 Financials and Milestone Developments

CRANBURY, NJ -- (MARKET WIRE) -- November 1, 2006 -- Valera Pharmaceuticals (NASDAQ: VLRX) today said it will report its third-quarter 2006 financial results on Wednesday morning, November 8, 2006.

The Company will conduct a conference call on November 8, 2006, at 8:30 a.m. ET to discuss its financial results and progress with respect to certain milestones and product pipeline developments. The conference call will be available via phone at 1-800-289-0528 and via webcast which can be accessed through the Media Center or Investor pages of Valera's corporate website at www.valerapharma.com. Please dial-in or login to the conference call several minutes prior to start time. A replay of the quarterly conference call will be available via the webcast link through November 30, 2006.

Separately, the Company reiterated that it will be presenting at the Rodman & Renshaw 8th Annual Healthcare Conference at the New York Palace Hotel on November 6, 2006 at 3:55 p.m. ET. The live presentation and archive will also be available on Valera's website.

About Valera Pharmaceuticals

Valera Pharmaceuticals is a specialty pharmaceutical company engaged in the development, acquisition, and commercialization of products to treat urology and endocrinology diseases and disorders. VANTAS®, a patent protected once-per-year implant that utilizes the Company's Hydron implant technology, is currently marketed by Valera for the palliative treatment of advanced prostate cancer.

Contact Information


  • Contact at Valera Pharmaceuticals
    Stuart Z. Levine, Ph.D.
    Director, Investor Relations
    609-409-9010 Ext. 3202
    Email Contact